86 related articles for article (PubMed ID: 19000654)
1. A cross-talk between oncogenic Ras and tumor suppressor PTEN through FAK Tyr861 phosphorylation in NIH/3T3 mouse embryonic fibroblasts.
Bahk YY; Cho IH; Kim TS
Biochem Biophys Res Commun; 2008 Dec; 377(4):1199-204. PubMed ID: 19000654
[TBL] [Abstract][Full Text] [Related]
2. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts.
Lim Y; Han I; Jeon J; Park H; Bahk YY; Oh ES
J Biol Chem; 2004 Jul; 279(28):29060-5. PubMed ID: 15123632
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of focal adhesion kinase at Tyrosine 407 negatively regulates Ras transformation of fibroblasts.
Jeon J; Lee H; Park H; Lee JH; Choi S; Hwang J; Han IO; Oh ES
Biochem Biophys Res Commun; 2007 Dec; 364(4):1062-6. PubMed ID: 17976369
[TBL] [Abstract][Full Text] [Related]
5. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
6. Induction of MAP kinase phosphatase 3 through Erk/MAP kinase activation in three oncogenic Ras (H-, K- and N-Ras)-expressing NIH/3T3 mouse embryonic fibroblast cell lines.
Koo J; Wang S; Kang N; Hur SJ; Bahk YY
BMB Rep; 2016 Jul; 49(7):370-5. PubMed ID: 26818088
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110δ phosphoinositide-3 kinase.
Tzenaki N; Aivaliotis M; Papakonstanti EA
FASEB J; 2015 Dec; 29(12):4840-52. PubMed ID: 26251180
[TBL] [Abstract][Full Text] [Related]
8. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1.
Chappell WH; Green TD; Spengeman JD; McCubrey JA; Akula SM; Bertrand FE
Cell Cycle; 2005 Oct; 4(10):1389-95. PubMed ID: 16096376
[TBL] [Abstract][Full Text] [Related]
9. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
Tamura M; Gu J; Takino T; Yamada KM
Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
[TBL] [Abstract][Full Text] [Related]
11. An enhanced association of RACK1 with Abl in cells transfected with oncogenic ras.
Huang CC; Liu CH; Chuang NN
Int J Biochem Cell Biol; 2008; 40(3):423-31. PubMed ID: 17881279
[TBL] [Abstract][Full Text] [Related]
12. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST.
Zheng Y; Xia Y; Hawke D; Halle M; Tremblay ML; Gao X; Zhou XZ; Aldape K; Cobb MH; Xie K; He J; Lu Z
Mol Cell; 2009 Jul; 35(1):11-25. PubMed ID: 19595712
[TBL] [Abstract][Full Text] [Related]
13. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.
Shuman JD; Sebastian T; Kaldis P; Copeland TD; Zhu S; Smart RC; Johnson PF
Mol Cell Biol; 2004 Sep; 24(17):7380-91. PubMed ID: 15314150
[TBL] [Abstract][Full Text] [Related]
15. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts.
Ahn JH; Ahn SK; Lee M
Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679
[TBL] [Abstract][Full Text] [Related]
16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
17. A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells.
Park JW; Kim S; Bahk YY
Proteomics; 2006 Apr; 6(8):2433-43. PubMed ID: 16612794
[TBL] [Abstract][Full Text] [Related]
18. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
19. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
